Kura Oncology, Inc. (KURA) Form 10-K Annual Reports
Kura Oncology, Inc. (KURA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KURA
CIK: 1422143
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMark Montoya
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-29 | 2026-09-28 | 4 | 0001193125-26-407939 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-28 | 4 | 0001193125-26-407938 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-28 | 4 | 0001193125-26-407937 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-28 | 4 | 0001193125-26-407936 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-28 | 4 | 0001193125-26-407935 | View SEC Doc Filr Page |
| 144 | 2026-09-29 | — | 144 Filing | 0001950047-26-009866 | View SEC Doc Filr Page |
| 144 | 2026-09-29 | — | 144 Filing | 0001950047-26-009865 | View SEC Doc Filr Page |
| 144 | 2026-09-29 | — | 144 Filing | 0001950047-26-009864 | View SEC Doc Filr Page |
| 144 | 2026-09-28 | — | 144 Filing | 0001193125-26-405751 | View SEC Doc Filr Page |
| 144 | 2026-09-28 | — | 144 Filing | 0001193125-26-405713 | View SEC Doc Filr Page |
| 144 | 2026-09-28 | — | 144 Filing | 0001193125-26-405712 | View SEC Doc Filr Page |
| 144 | 2026-09-28 | — | 144 Filing | 0001193125-26-405711 | View SEC Doc Filr Page |
| 144 | 2026-09-28 | — | 144 Filing | 0001193125-26-405710 | View SEC Doc Filr Page |
| 144 | 2026-09-28 | — | 144 Filing | 0001950047-26-009845 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-24 | 4 | 0001193125-26-402815 | View SEC Doc Filr Page |
| 144 | 2026-09-24 | — | 144 Filing | 0001950047-26-009786 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | 4 | 0001193125-26-387934 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | 3 | 0001193125-26-387926 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001193125-26-385881 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001193125-26-384363 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-24 | 4 | 0001193125-26-363812 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-21 | 4 | 0001193125-26-363810 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001950047-26-008548 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001193125-26-361184 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001950047-26-008396 | View SEC Doc Filr Page |